BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8627579)

  • 1. Discriminative stimulus effects on enadoline in pigeons.
    Brandt MR; France CP
    J Pharmacol Exp Ther; 1996 May; 277(2):960-7. PubMed ID: 8627579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.
    Carey GJ; Bergman J
    J Pharmacol Exp Ther; 2001 Apr; 297(1):215-23. PubMed ID: 11259547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):195-202. PubMed ID: 3612524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
    Walker EA; Picker MJ; Granger A; Dykstra LA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1990 Aug; 254(2):626-32. PubMed ID: 2384889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
    Picker M; Dykstra LA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the discriminative stimulus effects of buprenorphine in pigeons.
    Galici R; Brandt MR; France CP
    Psychopharmacology (Berl); 2002 Mar; 160(2):132-9. PubMed ID: 11875630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1988 Feb; 244(2):599-605. PubMed ID: 3346837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure.
    Picker MJ
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1190-8. PubMed ID: 8138931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans.
    Walsh SL; Geter-Douglas B; Strain EC; Bigelow GE
    J Pharmacol Exp Ther; 2001 Oct; 299(1):147-58. PubMed ID: 11561074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U-50, 488, saline and naltrexone discrimination in U-50, 488-treated pigeons.
    France CP; Woods JH
    Behav Pharmacol; 1993 Oct; 4(5):509-516. PubMed ID: 11224218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1989 Sep; 250(3):937-43. PubMed ID: 2550623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in sensitivity to the rate-decreasing effects of opioids in pigeons treated acutely or chronically with nalbuphine.
    Gerak LR; France CP
    Behav Pharmacol; 1996 Oct; 7(5):437-447. PubMed ID: 11224439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.